Andrea Gonzales , PhD
1355 Bogue St Room B346
Employment
Professor and Director of Drug Discovery, Michigan State University, East Lansing, 2025 - Present
Publications
Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitis Journal of Veterinary Pharmacology and Therapeutics (2024)
Comparison of intradermal and serum testing for environmental allergen‐specific immunoglobulin E determination in a laboratory colony of cats with naturally acquired atopic syndrome Veterinary Dermatology (2024)
Cytokine transcriptome profiling in acute experimental canine atopic dermatitis skin lesions after IL‐31 inhibition with lokivetmab Veterinary Dermatology (2023)
Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL‐31‐induced pruritus Journal of Veterinary Pharmacology and Therapeutics (2022)
Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus Veterinary Dermatology (2021)